The result of data analysis showed that FXYD6 was reduced obviously in the resistant group (R) compared to the sensitive group (S), which suggested that the lower expression level of FXYD6 was positively correlated to Iri and Oxa resistance in CRC (Figure 1(a)). The gene discussed is FXYD6; the disease is colorectal carcinoma.